Dermata Therapeutics Announces Commercial Launch Date for Tome(TM) Foundational Treatment

Go back to Dermata Therapeutics Announces Commercial Launch Date for Tome(TM) Foundational Treatment
(NASDAQ: DRMA) Delayed: 1.12 -0.01 (0.88%)
Previous Close $1.13    52 Week High $ 
Open $1.14    52 Week Low $ 
Day High $1.14    P/E N/A 
Day Low $1.11    EPS $ 
Volume 7,422